Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the efficacy and the safety of
pegfilgrastim versus filgrastim, administered after high-dose chemotherapy and peripheral
stem cell reinfusion.